Balentine LLC’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,405
| Closed | -$1.4M | – | 533 |
|
|
2024
Q1 | $1.4M | Buy |
2,405
+378
| +19% | +$212K | 0.04% | 140 |
|
|
2023
Q4 | $1.08M | Sell |
2,027
-2,213
| -52% | -$1.07M | 0.03% | 157 |
|
|
2023
Q3 | $2.15M | Buy |
4,240
+337
| +9% | +$180K | 0.07% | 85 |
|
|
2023
Q2 | $2.04M | Sell |
3,903
-935
| -19% | -$505K | 0.07% | 88 |
|
|
2023
Q1 | $2.79M | Buy |
4,838
+443
| +10% | +$250K | 0.09% | 76 |
|
|
2022
Q4 | $2.42M | Buy |
4,395
+198
| +5% | +$105K | 0.08% | 89 |
|
|
2022
Q3 | $2.13M | Sell |
4,197
-1,441
| -26% | -$806K | 0.08% | 75 |
|
|
2022
Q2 | $3.06M | Buy |
5,638
+699
| +14% | +$385K | 0.11% | 70 |
|
|
2022
Q1 | $2.92M | Buy |
4,939
+2,885
| +140% | +$1.66M | 0.1% | 53 |
|
|
2021
Q4 | $1.37M | Buy |
2,054
+334
| +19% | +$209K | 0.05% | 67 |
|
|
2021
Q3 | $983K | Buy |
1,720
+959
| +126% | +$526K | 0.04% | 65 |
|
|
2021
Q2 | $384K | Buy |
761
+76
| +11% | +$35.9K | 0.02% | 98 |
|
|
2021
Q1 | $313K | Buy |
685
+6
| +0.9% | +$2.86K | 0.01% | 107 |
|
|
2020
Q4 | $316K | Buy |
679
+35
| +5% | +$16.4K | 0.01% | 100 |
|
|
2020
Q3 | $284K | Buy |
644
+62
| +11% | +$25.6K | 0.01% | 96 |
|
|
2020
Q2 | $211K | Sell |
582
-7
| -1% | -$2.35K | 0.01% | 95 |
|
|
2020
Q1 | $167K | Buy |
589
+238
| +68% | +$75K | 0.01% | 75 |
|
|
2019
Q4 | $114K | Buy |
351
+305
| +663% | +$92.5K | 0.01% | 110 |
|
|
2019
Q3 | $13K | Hold |
46
| – | – | ﹤0.01% | 302 |
|
|
2019
Q2 | $14K | Buy |
+46
| New | +$12.7K | ﹤0.01% | 261 |
|
|
2018
Q3 | – | Sell |
-139
| Closed | -$29K | – | 389 |
|
|
2018
Q2 | $29K | Buy |
+139
| New | +$29.5K | ﹤0.01% | 43 |
|
|
2018
Q1 | – | Sell |
-429
| Closed | -$81K | – | 475 |
|
|
2017
Q4 | $81K | Hold |
429
| – | – | 0.01% | 217 |
|
|
2017
Q3 | $81K | Hold |
429
| – | – | 0.01% | 208 |
|
|
2017
Q2 | $75K | Buy |
429
+129
| +43% | +$21.7K | 0.01% | 201 |
|
|
2017
Q1 | $46K | Hold |
300
| – | – | ﹤0.01% | 232 |
|
|
2016
Q4 | $42K | Buy |
300
+6
| +2% | +$885 | ﹤0.01% | 229 |
|
|
2016
Q3 | $47K | Hold |
294
| – | – | 0.01% | 171 |
|
|
2016
Q2 | $43K | Buy |
+294
| New | +$43.4K | 0.01% | 161 |
|
|
2015
Q3 | – | Sell |
-14
| Closed | -$2K | – | 479 |
|
|
2015
Q2 | $2K | Buy |
+14
| New | +$1.82K | ﹤0.01% | 371 |
|
Other funds holding TMO
Balentine LLC's TMO Position: Q2 2024 in Review
Balentine LLC sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 2,405 shares — an estimated $1.4M sold.
Balentine LLC first reported a position in TMO in Q2 2015 and held it in 29 quarters. The position peaked at $3.06M in Q2 2022. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.
- Balentine LLC reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
- Balentine LLC sold 2,405 Thermo Fisher Scientific shares in Q2 2024, an estimated $1.4M.
- Balentine LLC first reported a position in Thermo Fisher Scientific in Q2 2015 and held it in 29 quarters.
- Balentine LLC's Thermo Fisher Scientific position peaked at $3.06M in Q2 2022.
- 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.
Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.